General Information of Drug (ID: DMSUWVE)

Drug Name
ISIS 29177 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMSUWVE

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SB-747651A DM20Q5O Discovery agent N.A. Investigative [2]
ISIS 29202 DMDR8V9 Discovery agent N.A. Investigative [1]
ISIS 29136 DMAMTLR Discovery agent N.A. Investigative [1]
ISIS 29112 DMECMA6 Discovery agent N.A. Investigative [1]
ISIS 29161 DMPS6OQ Discovery agent N.A. Investigative [1]
ISIS 29200 DMN1LHI Discovery agent N.A. Investigative [1]
ISIS 29135 DMGJURC Discovery agent N.A. Investigative [1]
ISIS 29160 DM9NB1A Discovery agent N.A. Investigative [1]
ISIS 29176 DMVLU5J Discovery agent N.A. Investigative [1]
ISIS 29159 DMLE1IJ Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
AKT3 messenger RNA (AKT3 mRNA) TTO6SGY AKT3_HUMAN Not Available [1]

References

1 US patent application no. 6,187,586, Antisense modulation of AKT-3 expression.
2 Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-o... J Med Chem. 2008 Sep 25;51(18):5663-79.